Scorecard › AMZN
AMZN analyst scorecard · Amazon
148 rating actions on AMZN in the last 12 months. Of 300 price targets that resolved, 45 were reached while they stood, 246 were replaced by the same firm first, and 9 fell short at their deadline. Ratings: 98% Buy-type, 2% Hold-type, 0% Sell-type. Consensus target $332, 36% above the last close.
Checked through 2026-10-29 · last close $245.40 (2026-10-29). Rebuilt every morning.
Targets reached while they stood
15.0% 45 of 300
Replaced before the deadline
82.0%
Short at the deadline
3.0%
Ratings vs XLY
32 of 43
Buy / Hold / Sell, 12 mo
98 / 2 / 0%
Consensus target
$332 +35.5%
What the Holds say: 3 Hold-type ratings on AMZN in the last 12 months carried a median target -8% from the price on the day; 67% sat below it.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| BMO Capital | Outperform | 2026-07-28 | $360 | 0 | 11 | 11 | 1 of 1 |
| Rosenblatt | Buy | 2026-09-30 | $360 | 1 | 11 | 12 | 1 of 1 |
| Citizens | Market Outperform | 2026-07-31 | $315 | 0 | 2 | 2 | — |
| Mizuho | Outperform | 2026-07-31 | $330 | 0 | 6 | 6 | 0 of 1 |
| Needham | Buy | 2026-07-31 | $300 | 6 | 5 | 11 | 1 of 1 |
| Oppenheimer | Outperform | 2026-04-24 | $275 | 4 | 5 | 9 | 1 of 1 |
| TD Cowen | Buy | 2026-10-05 | $350 | 0 | 10 | 10 | 1 of 1 |
| Cantor Fitzgerald | Overweight | 2026-10-12 | $310 | 0 | 14 | 14 | 0 of 1 |
| Wells Fargo | Overweight | 2026-10-12 | $329 | 0 | 16 | 16 | 1 of 1 |
| UBS | Buy | 2026-10-26 | $348 | 1 | 12 | 13 | 1 of 1 |
| Citigroup | Buy | 2026-07-31 | $350 | 1 | 7 | 8 | 0 of 1 |
| Wedbush | Outperform | 2026-07-31 | $310 | 0 | 14 | 14 | 1 of 1 |
| Truist Securities | Buy | 2026-07-31 | $350 | 0 | 10 | 10 | 1 of 1 |
| KeyBanc | Overweight | 2026-07-31 | $350 | 0 | 5 | 5 | — |
| RBC Capital | Outperform | 2026-07-31 | $330 | 3 | 4 | 7 | 1 of 1 |
| Piper Sandler | Overweight | 2026-07-31 | $320 | 3 | 6 | 9 | 1 of 1 |
| JPMorgan | Overweight | 2026-07-31 | $365 | 0 | 11 | 11 | 1 of 1 |
| Stifel | Buy | 2026-05-01 | $319 | 0 | 10 | 10 | 1 of 1 |
| Bank of America | Buy | 2026-04-20 | $298 | 1 | 9 | 10 | 1 of 1 |
| Telsey Advisory Group | Outperform | 2026-07-31 | $335 | 1 | 12 | 13 | 1 of 1 |
| Tigress Financial | Buy | 2026-10-06 | $385 | 0 | 3 | 3 | 0 of 1 |
| Argus Research | Buy | 2026-02-06 | $325 | — | — | 0 | — |
| Guggenheim | Buy | 2026-04-30 | $320 | 0 | 2 | 2 | — |
| Morgan Stanley | Overweight | 2026-10-19 | $350 | 1 | 6 | 7 | 1 of 1 |
| Scotiabank | Sector Outperform | 2026-04-30 | $325 | 0 | 5 | 5 | 1 of 1 |
| Evercore ISI Group | Outperform | 2026-04-30 | $315 | 0 | 5 | 5 | 1 of 1 |
| Bernstein | Outperform | 2026-07-31 | $320 | 1 | 6 | 7 | 1 of 1 |
| DA Davidson | Neutral | 2026-07-31 | $250 | 2 | 4 | 6 | — |
| Benchmark | Buy | 2026-07-31 | $400 | 1 | 8 | 9 | 1 of 1 |
| Barclays | Overweight | 2026-07-31 | $365 | 0 | 5 | 5 | 0 of 1 |
| Canaccord Genuity | Buy | 2026-04-30 | $330 | 0 | 3 | 3 | 0 of 1 |
| Susquehanna | Positive | 2026-04-30 | $325 | 3 | 0 | 3 | 1 of 1 |
| Roth Capital | Buy | 2026-01-26 | $295 | 1 | 0 | 1 | 1 of 1 |
| Jefferies | Buy | 2026-01-05 | $300 | 1 | 2 | 3 | 1 of 1 |
| Rothschild & Co | Neutral | 2025-11-18 | $250 | 1 | 0 | 1 | — |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor AMZN carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-26 | UBS | Buy | maintained | $249.09 | $348 | running to 2027-10-26 | -0.2% |
| 2026-10-19 | Morgan Stanley | Overweight | maintained | $262.45 | $350 | running to 2028-04-19 | +3.4% |
| 2026-10-12 | Wells Fargo | Overweight | maintained | $259.53 | $329 | running to 2027-10-12 | +1.1% |
| 2026-10-12 | Cantor Fitzgerald | Overweight | maintained | $259.53 | $310 | running to 2027-10-12 | +1.1% |
| 2026-10-06 | Tigress Financial | Buy | maintained | $256.29 | $385 | running to 2027-10-06 | -0.9% |
| 2026-10-05 | TD Cowen | Buy | reiterated | $251.40 | $350 | running to 2027-10-05 | -2.8% |
| 2026-09-30 | Rosenblatt | Buy | maintained | $249.15 | $360 | running to 2027-09-30 | -4.1% |
| 2026-09-03 | Wells Fargo | Overweight | maintained | $258.90 | $338 | replaced 2026-10-12, new $329 | -6.7% |
| 2026-07-31 | UBS | Buy | maintained | $271.58 | $318 | replaced 2026-10-26, new $348 | +12.4% |
| 2026-07-31 | Telsey Advisory Group | Outperform | maintained | $271.58 | $335 | running to 2027-07-31 | +12.4% |
| 2026-07-31 | Bernstein | Outperform | maintained | $271.58 | $320 | running to 2027-07-31 | +12.4% |
| 2026-07-31 | Citigroup | Buy | maintained | $271.58 | $350 | running to 2027-07-31 | +12.4% |
| 2026-07-31 | RBC Capital | Outperform | maintained | $271.58 | $330 | running to 2027-07-31 | +12.4% |
| 2026-07-31 | Mizuho | Outperform | maintained | $271.58 | $330 | running to 2027-07-31 | +12.4% |
| 2026-07-31 | TD Cowen | Buy | maintained | $271.58 | $350 | running to 2027-07-31 | +12.4% |
| 2026-07-31 | DA Davidson | Neutral | maintained | $271.58 | $250 | reached 2026-09-15 | +12.4% |
| 2026-07-31 | Wells Fargo | Overweight | maintained | $271.58 | $328 | replaced 2026-09-03, new $338 | +12.4% |
| 2026-07-31 | Cantor Fitzgerald | Overweight | maintained | $271.58 | $320 | replaced 2026-10-12, new $310 | +12.4% |
| 2026-07-31 | Piper Sandler | Overweight | reiterated | $271.58 | $320 | running to 2027-07-31 | +12.4% |
| 2026-07-31 | Benchmark | Buy | maintained | $271.58 | $400 | running to 2027-07-31 | +12.4% |
| 2026-07-31 | Wedbush | Outperform | maintained | $271.58 | $310 | running to 2027-07-31 | +12.4% |
| 2026-07-31 | Truist Securities | Buy | maintained | $271.58 | $350 | running to 2027-07-31 | +12.4% |
| 2026-07-31 | Citizens | Market Outperform | reiterated | $271.58 | $315 | running to 2027-07-31 | +12.4% |
| 2026-07-31 | Needham | Buy | reiterated | $271.58 | $300 | running to 2027-07-31 | +12.4% |
| 2026-07-31 | KeyBanc | Overweight | maintained | $271.58 | $350 | running to 2027-07-31 | +12.4% |
| 2026-07-31 | Rosenblatt | Buy | maintained | $271.58 | $345 | replaced 2026-09-30, new $360 | +12.4% |
| 2026-07-31 | Barclays | Overweight | maintained | $271.58 | $365 | running to 2027-07-31 | +12.4% |
| 2026-07-31 | JPMorgan | Overweight | maintained | $271.58 | $365 | running to 2027-07-31 | +12.4% |
| 2026-07-28 | UBS | Buy | maintained | $230.86 | $305 | replaced 2026-07-31, new $318 | -0.8% |
| 2026-07-28 | BMO Capital | Outperform | maintained | $230.86 | $360 | running to 2027-07-28 | -0.8% |
| 2026-07-28 | Mizuho | Outperform | maintained | $230.86 | $320 | replaced 2026-07-31, new $330 | -0.8% |
| 2026-07-23 | Wedbush | Outperform | reiterated | $233.66 | $293 | replaced 2026-07-31, new $310 | -0.2% |
| 2026-07-21 | Wells Fargo | Overweight | maintained | $247.55 | $322 | replaced 2026-07-31, new $328 | +1.3% |
| 2026-07-16 | KeyBanc | Overweight | maintained | $249.89 | $335 | replaced 2026-07-31, new $350 | +1.6% |
| 2026-07-15 | Citizens | Market Outperform | reiterated | $254.96 | $315 | running to 2027-07-15 | +3.6% |
| 2026-07-08 | TD Cowen | Buy | maintained | $243.62 | $340 | replaced 2026-07-31, new $350 | -0.7% |
| 2026-07-02 | Wells Fargo | Overweight | maintained | $242.67 | $313 | replaced 2026-07-21, new $322 | -5.4% |
| 2026-05-29 | Truist Securities | Buy | maintained | $270.64 | $320 | replaced 2026-07-31, new $350 | +2.9% |
| 2026-05-20 | Wells Fargo | Overweight | maintained | $265.01 | $312 | replaced 2026-07-02, new $313 | +6.7% |
| 2026-05-12 | TD Cowen | Buy | reiterated | $265.82 | $350 | replaced 2026-07-08, new $340 | +11.5% |
| 2026-05-01 | Stifel | Buy | maintained | $268.26 | $319 | running to 2027-05-01 | +27.4% |
| 2026-04-30 | Telsey Advisory Group | Outperform | maintained | $265.06 | $315 | replaced 2026-07-31, new $335 | +27.3% |
| 2026-04-30 | Canaccord Genuity | Buy | maintained | $265.06 | $330 | running to 2027-04-30 | +27.3% |
| 2026-04-30 | JPMorgan | Overweight | maintained | $265.06 | $330 | replaced 2026-07-31, new $365 | +27.3% |
| 2026-04-30 | TD Cowen | Buy | maintained | $265.06 | $350 | replaced 2026-07-08, new $340 | +27.3% |
| 2026-04-30 | Bernstein | Outperform | maintained | $265.06 | $315 | replaced 2026-07-31, new $320 | +27.3% |
| 2026-04-30 | Citigroup | Buy | maintained | $265.06 | $325 | replaced 2026-07-31, new $350 | +27.3% |
| 2026-04-30 | Morgan Stanley | Overweight | maintained | $265.06 | $330 | replaced 2026-10-19, new $350 | +27.3% |
| 2026-04-30 | Susquehanna | Positive | maintained | $265.06 | $325 | running to 2027-04-30 | +27.3% |
| 2026-04-30 | RBC Capital | Outperform | maintained | $265.06 | $320 | replaced 2026-07-31, new $330 | +27.3% |
| 2026-04-30 | Piper Sandler | Overweight | reiterated | $265.06 | $315 | replaced 2026-07-31, new $320 | +27.3% |
| 2026-04-30 | Guggenheim | Buy | maintained | $265.06 | $320 | running to 2027-04-30 | +27.3% |
| 2026-04-30 | Barclays | Overweight | maintained | $265.06 | $330 | replaced 2026-07-31, new $365 | +27.3% |
| 2026-04-30 | Evercore ISI Group | Outperform | maintained | $265.06 | $315 | running to 2027-04-30 | +27.3% |
| 2026-04-30 | Wells Fargo | Overweight | maintained | $265.06 | $313 | replaced 2026-05-20, new $312 | +27.3% |
| 2026-04-30 | Benchmark | Buy | maintained | $265.06 | $370 | replaced 2026-07-31, new $400 | +27.3% |
| 2026-04-30 | Cantor Fitzgerald | Overweight | maintained | $265.06 | $330 | replaced 2026-07-31, new $320 | +27.3% |
| 2026-04-30 | KeyBanc | Overweight | maintained | $265.06 | $330 | replaced 2026-07-16, new $335 | +27.3% |
| 2026-04-30 | Rosenblatt | Buy | maintained | $265.06 | $332 | replaced 2026-07-31, new $345 | +27.3% |
| 2026-04-30 | Truist Securities | Buy | maintained | $265.06 | $310 | replaced 2026-05-29, new $320 | +27.3% |
| 2026-04-30 | Scotiabank | Sector Outperform | maintained | $265.06 | $325 | running to 2027-04-30 | +27.3% |
| 2026-04-30 | Needham | Buy | maintained | $265.06 | $300 | running to 2027-04-30 | +27.3% |
| 2026-04-28 | Mizuho | Outperform | maintained | $259.70 | $325 | replaced 2026-07-28, new $320 | +30.3% |
| 2026-04-24 | Oppenheimer | Outperform | maintained | $263.99 | $275 | within 5% of price when set | +24.7% |
| 2026-04-23 | UBS | Buy | maintained | $255.08 | $304 | replaced 2026-07-28, new $305 | +23.1% |
| 2026-04-23 | BMO Capital | Outperform | maintained | $255.08 | $315 | replaced 2026-07-28, new $360 | +23.1% |
| 2026-04-21 | Cantor Fitzgerald | Overweight | maintained | $249.91 | $280 | replaced 2026-04-30, new $330 | +21.7% |
| 2026-04-20 | KeyBanc | Overweight | maintained | $248.28 | $325 | replaced 2026-04-30, new $330 | +20.9% |
| 2026-04-20 | Bank of America | Buy | maintained | $248.28 | $298 | running to 2027-04-20 | +20.9% |
| 2026-04-17 | Truist Securities | Buy | maintained | $250.56 | $285 | replaced 2026-04-30, new $310 | +19.4% |
| 2026-04-16 | TD Cowen | Buy | reiterated | $249.70 | $300 | replaced 2026-04-30, new $350 | +16.0% |
| 2026-04-15 | Citizens | Market Outperform | reiterated | $248.50 | $315 | running to 2027-04-15 | +17.4% |
| 2026-04-15 | Rosenblatt | Buy | maintained | $248.50 | $296 | replaced 2026-04-30, new $332 | +17.4% |
| 2026-04-13 | Stifel | Buy | maintained | $239.89 | $294 | replaced 2026-05-01, new $319 | +15.5% |
| 2026-04-10 | Citizens | Market Outperform | reiterated | $238.38 | $315 | running to 2027-04-10 | +12.1% |
| 2026-04-08 | Cantor Fitzgerald | Overweight | maintained | $221.25 | $260 | replaced 2026-04-21, new $280 | +3.6% |
| 2026-04-02 | Wells Fargo | Overweight | maintained | $209.77 | $305 | replaced 2026-04-30, new $313 | +0.5% |
| 2026-03-25 | Tigress Financial | Buy | maintained | $211.71 | $315 | replaced 2026-10-06, new $385 | +3.1% |
| 2026-03-25 | JPMorgan | Overweight | maintained | $211.71 | $280 | replaced 2026-04-30, new $330 | +3.1% |
| 2026-03-25 | Citigroup | Buy | maintained | $211.71 | $285 | replaced 2026-04-30, new $325 | +3.1% |
| 2026-03-23 | TD Cowen | Buy | reiterated | $210.14 | $300 | replaced 2026-04-30, new $350 | +0.0% |
| 2026-03-17 | Needham | Buy | reiterated | $215.20 | $265 | reached 2026-04-30 | +8.2% |
| 2026-02-23 | Wells Fargo | Overweight | maintained | $205.27 | $304 | replaced 2026-04-02, new $305 | -14.2% |
| 2026-02-09 | Citigroup | Buy | maintained | $208.72 | $265 | replaced 2026-03-25, new $285 | -15.6% |
| 2026-02-06 | Wells Fargo | Overweight | maintained | $210.32 | $305 | replaced 2026-02-23, new $304 | -12.9% |
| 2026-02-06 | RBC Capital | Outperform | reiterated | $210.32 | $300 | replaced 2026-04-30, new $320 | -12.9% |
| 2026-02-06 | Oppenheimer | Outperform | maintained | $210.32 | $260 | reached 2026-04-24 | -12.9% |
| 2026-02-06 | Argus Research | Buy | reiterated | $210.32 | $325 | running to 2027-02-06 | -12.9% |
| 2026-02-06 | Citizens | Market Outperform | reiterated | $210.32 | $315 | running to 2027-02-06 | -12.9% |
| 2026-02-06 | Cantor Fitzgerald | Overweight | maintained | $210.32 | $250 | replaced 2026-04-08, new $260 | -12.9% |
| 2026-02-06 | Piper Sandler | Overweight | reiterated | $210.32 | $260 | reached 2026-04-24 | -12.9% |
| 2026-02-06 | Guggenheim | Buy | maintained | $210.32 | $300 | replaced 2026-04-30, new $320 | -12.9% |
| 2026-02-06 | Scotiabank | Sector Outperform | maintained | $210.32 | $275 | replaced 2026-04-30, new $325 | -12.9% |
| 2026-02-06 | DA Davidson | Buy → Neutral | downgrade | $210.32 | $175 | replaced 2026-07-31, new $250 | -12.9% |
| 2026-02-06 | Wedbush | Outperform | maintained | $210.32 | $300 | replaced 2026-07-23, new $293 | -12.9% |
| 2026-02-06 | Telsey Advisory Group | Outperform | maintained | $210.32 | $300 | replaced 2026-04-30, new $315 | -12.9% |
| 2026-02-06 | Rosenblatt | Buy | maintained | $210.32 | $296 | replaced 2026-04-30, new $332 | -12.9% |
| 2026-02-06 | BMO Capital | Outperform | maintained | $210.32 | $310 | replaced 2026-04-23, new $315 | -12.9% |
| 2026-02-06 | Truist Securities | Buy | maintained | $210.32 | $280 | replaced 2026-04-17, new $285 | -12.9% |
| 2026-02-06 | Evercore ISI Group | Outperform | maintained | $210.32 | $285 | replaced 2026-04-30, new $315 | -12.9% |
| 2026-02-06 | Morgan Stanley | Overweight | maintained | $210.32 | $300 | replaced 2026-04-30, new $330 | -12.9% |
| 2026-02-06 | Needham | Buy | reiterated | $210.32 | $265 | reached 2026-04-30 | -12.9% |
| 2026-02-03 | UBS | Buy | maintained | $238.62 | $311 | replaced 2026-04-23, new $304 | +5.3% |
| 2026-02-02 | Citizens | Market Outperform | maintained | $242.96 | $315 | running to 2027-02-02 | +7.3% |
| 2026-01-30 | Telsey Advisory Group | Outperform | maintained | $239.30 | $300 | replaced 2026-04-30, new $315 | +3.7% |
| 2026-01-29 | Wedbush | Outperform | reiterated | $241.73 | $340 | replaced 2026-02-06, new $300 | +4.0% |
| 2026-01-28 | Oppenheimer | Outperform | maintained | $243.01 | $315 | replaced 2026-02-06, new $260 | +4.7% |
| 2026-01-28 | KeyBanc | Overweight | maintained | $243.01 | $308 | replaced 2026-04-20, new $325 | +4.7% |
| 2026-01-27 | Bank of America | Buy | maintained | $244.68 | $286 | replaced 2026-04-20, new $298 | +5.2% |
| 2026-01-27 | Stifel | Buy | maintained | $244.68 | $300 | replaced 2026-04-13, new $294 | +5.2% |
| 2026-01-26 | Roth Capital | Buy | maintained | $238.42 | $295 | running to 2027-01-26 | +2.5% |
| 2026-01-13 | TD Cowen | Buy | maintained | $242.60 | $315 | replaced 2026-03-23, new $300 | +7.2% |
| 2026-01-12 | Wells Fargo | Overweight | maintained | $246.47 | $301 | replaced 2026-02-06, new $305 | +9.0% |
| 2026-01-08 | Cantor Fitzgerald | Overweight | maintained | $246.29 | $260 | replaced 2026-02-06, new $250 | +8.1% |
| 2026-01-05 | Jefferies | Buy | maintained | $233.06 | $300 | running to 2027-01-05 | +1.5% |
| 2025-12-16 | BMO Capital | Outperform | maintained | $222.56 | $304 | replaced 2026-02-06, new $310 | -5.2% |
| 2025-12-11 | TD Cowen | Buy | reiterated | $230.28 | $300 | replaced 2026-01-13, new $315 | -7.6% |
| 2025-12-10 | Guggenheim | Buy | initiated | $231.78 | $300 | replaced 2026-04-30, new $320 | -6.7% |
| 2025-12-04 | Rosenblatt | Buy | maintained | $229.11 | $305 | replaced 2026-02-06, new $296 | -8.1% |
| 2025-12-03 | Wedbush | Outperform | reiterated | $232.38 | $340 | replaced 2026-02-06, new $300 | -8.5% |
| 2025-12-03 | Citizens | Market Outperform | reiterated | $232.38 | $300 | replaced 2026-02-02, new $315 | -8.5% |
| 2025-12-03 | Bank of America | Buy | maintained | $232.38 | $303 | replaced 2026-01-27, new $286 | -8.5% |
| 2025-12-02 | Wells Fargo | Overweight | maintained | $234.42 | $295 | replaced 2026-01-12, new $301 | -4.0% |
| 2025-12-01 | Oppenheimer | Outperform | maintained | $233.88 | $305 | replaced 2026-01-28, new $315 | -4.2% |
| 2025-11-25 | Rosenblatt | Buy | maintained | $229.67 | $305 | replaced 2026-02-06, new $296 | — |
| 2025-11-18 | Rothschild & Co | Buy → Neutral | downgrade | $222.55 | $250 | reached 2026-04-17 | — |
| 2025-11-04 | Rosenblatt | Buy | maintained | $249.32 | $305 | replaced 2026-02-06, new $296 | — |
| 2025-11-04 | Mizuho | Outperform | maintained | $249.32 | $315 | replaced 2026-04-28, new $325 | — |
| 2025-10-31 | Wells Fargo | Overweight | maintained | $244.22 | $292 | replaced 2025-12-02, new $295 | — |
| 2025-10-31 | Canaccord Genuity | Buy | maintained | $244.22 | $300 | replaced 2026-04-30, new $330 | — |
| 2025-10-31 | Citigroup | Buy | maintained | $244.22 | $320 | replaced 2026-02-09, new $265 | — |
| 2025-10-31 | JPMorgan | Overweight | maintained | $244.22 | $305 | replaced 2026-03-25, new $280 | — |
| 2025-10-31 | TD Cowen | Buy | maintained | $244.22 | $300 | replaced 2026-01-13, new $315 | — |
| 2025-10-31 | Piper Sandler | Overweight | reiterated | $244.22 | $300 | replaced 2026-02-06, new $260 | — |
| 2025-10-31 | Bernstein | Outperform | maintained | $244.22 | $300 | replaced 2026-04-30, new $315 | — |
| 2025-10-31 | UBS | Buy | maintained | $244.22 | $310 | replaced 2026-02-03, new $311 | — |
| 2025-10-31 | Barclays | Overweight | maintained | $244.22 | $300 | replaced 2026-04-30, new $330 | — |
| 2025-10-31 | RBC Capital | Outperform | maintained | $244.22 | $300 | replaced 2026-04-30, new $320 | — |
| 2025-10-31 | Benchmark | Buy | maintained | $244.22 | $295 | replaced 2026-04-30, new $370 | — |
| 2025-10-31 | Cantor Fitzgerald | Overweight | maintained | $244.22 | $315 | replaced 2026-01-08, new $260 | — |
| 2025-10-31 | DA Davidson | Buy | maintained | $244.22 | $300 | replaced 2026-02-06, new $175 | — |
| 2025-10-31 | KeyBanc | Overweight | maintained | $244.22 | $303 | replaced 2026-01-28, new $308 | — |
| 2025-10-31 | Evercore ISI Group | Outperform | maintained | $244.22 | $335 | replaced 2026-02-06, new $285 | — |
| 2025-10-31 | Rosenblatt | Buy | maintained | $244.22 | $305 | replaced 2026-02-06, new $296 | — |
| 2025-10-31 | Stifel | Buy | maintained | $244.22 | $295 | replaced 2026-01-27, new $300 | — |
| 2025-10-31 | Telsey Advisory Group | Outperform | maintained | $244.22 | $300 | replaced 2026-04-30, new $315 | — |
| 2025-10-31 | Bank of America | Buy | maintained | $244.22 | $303 | replaced 2026-01-27, new $286 | — |
| 2025-10-31 | Citizens | Market Outperform | maintained | $244.22 | $300 | replaced 2026-02-02, new $315 | — |
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.